Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

FREAMINE III 8.5% W/ ELECTROLYTES

AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE

Standard Dose
8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview FREAMINE III 8.5% W/ ELECTROLYTES is listed in Drugs@FDA under application 016822 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE Form and strength INJECTABLE;INJECTION - 8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100ML Sponsor B BRAUN Submission history Latest submission status date: 2014-03-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview FREAMINE III 8.5% W/ ELECTROLYTES is listed in Drugs@FDA under application 016822 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE Form and strength INJECTABLE;INJECTION - 8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100ML Sponsor B BRAUN Submission history Latest submission status date: 2014-03-12 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued
  • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.
FREAMINE III 8.5% W/ ELECTROLYTES (AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE) | Drug Monograph | MedicHelpline